Search

Yoram Ben Barak

from Belmont, CA
Age ~75

Yoram Barak Phones & Addresses

  • Belmont, CA
  • Costa Mesa, CA
  • San Jose, CA
  • Laguna Woods, CA
  • Murrieta, CA
  • Irvine, CA
  • Woodland Hills, CA
  • Riverside, CA

Work

Company: Codexis inc. Mar 2008 Position: Scientist iii

Education

School / High School: Stanford University- Stanford, CA 2004 Specialities: Postdoctoral fellow in Microbiology & Immunology

Skills

Experienced with Molecular Cloning techn... • gene/pathway cloning • knock in/out • saturation mutagenesis • tagging • DNA shuffling • Sequence activity relationship (SAR). ... • AKTA FPLC • protein SDS native and denatured gels. ... • medium and high throughput. Experien... • DNAstar • GeneData • LIMS. Keen and fast learner of new tec...

Resumes

Resumes

Yoram Barak Photo 1

Staff Scientist At Codexis Inc.

View page
Location:
San Francisco Bay Area
Industry:
Biotechnology
Yoram Barak Photo 2

Yoram Barak

View page
Yoram Barak Photo 3

Yoram Barak

View page
Yoram Barak Photo 4

Yoram Barak Menlo Park, CA

View page
Work:
Codexis Inc.

Mar 2008 to Present
Scientist III

Codexis, Spancrete, Otehrs

Extra curriculum activities

Education:
Stanford University
Stanford, CA
2004 to 2008
Postdoctoral fellow in Microbiology & Immunology

Hebrew University of Jerusalem
,
1998 to 2002
PhD in Environmental Microbiology

Skills:
Experienced with Molecular Cloning techniques including but not limited to PCR, gene/pathway cloning, knock in/out, saturation mutagenesis, tagging, DNA shuffling, Sequence activity relationship (SAR). Experienced with variety of chromatography techniques including HPLC GC-FID. Proficiency with Agilent Chemstation software. Experienced with fluorescence and bioluminescence assays and spectrometry. Microbiology techniques including isolation and culturing of difficult microorganisms. Experienced with Biolog phenotypic array system. Experienced protein purification affinity tag purification, AKTA FPLC, protein SDS native and denatured gels. Experienced with developing effective screens for low, medium and high throughput. Experienced with determining enzyme kinetics. Experienced with Molecular Imaging and in vivo small animal models for cancer research. Familiar with Eukaryotes cell culturing and efficacy assay. Experienced user Microsoft Office, DNAstar, GeneData, LIMS. Keen and fast learner of new techniques. Multitasking and able to work on multiple projects with effective problem solving. High attention to details. Team player with strong soft skills. Strong mentoring skills.
Yoram Barak Photo 5

Yoram Barak

View page

Publications

Us Patents

Nitroreductase Enzymes

View page
US Patent:
7687474, Mar 30, 2010
Filed:
Dec 20, 2006
Appl. No.:
11/643628
Inventors:
A. C. Matin - Stanford CA, US
Yoram Barak - Menlo Park CA, US
Susan V. Lynch - San Francisco CA, US
David F. Ackerley - Wellington, NZ
Stephen H. Thorne - Palo Alto CA, US
Christopher H. Contag - Stanford CA, US
Jianghong Rao - Palo Alto CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61K 48/00
C12N 5/00
US Classification:
514 44, 4353201
Abstract:
Compositions and methods are provided for the treatment of cancer.

Nitroreductase Enzymes For Bioremediation

View page
US Patent:
7754470, Jul 13, 2010
Filed:
Dec 20, 2006
Appl. No.:
11/643199
Inventors:
A. C. Matin - Stanford CA, US
Yoram Barak - Menlo Park CA, US
David F. Ackerley - Wellington, NZ
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A62D 3/00
C12N 9/02
C12N 9/00
C12Q 1/26
C12P 21/06
C12N 1/20
C07H 21/04
US Classification:
4352625, 435189, 435183, 435 25, 435 691, 4352523, 536 232, 536 237
Abstract:
Compositions and methods are provided for bioremediation of toxic metals.

Magnetotactic Bacteria Mri Positive Contrast Enhancement Agent And Methods Of Use

View page
US Patent:
20100135912, Jun 3, 2010
Filed:
Nov 30, 2009
Appl. No.:
12/627299
Inventors:
Sanjiv S. Gambhir - Portola Valley CA, US
Michael Benoit - Menlo Park CA, US
A. C. Matin - Stanford CA, US
Yoram Barak - Menlo Park CA, US
Shay Keren - Haifa, IL
Dirk Mayer - Menlo Park CA, US
International Classification:
A61K 49/08
C12N 1/20
US Classification:
424 932, 4352521
Abstract:
Magnetic resonance imaging (MRI) is enhanced by contrast agents such as superparamagnetic iron-oxide (SPIO) particles that resemble magnetite particles produced by magnetotactic bacteria. AMB-1 produces positive MRI contrast when generating ultrasmall magnetite particles (10-40 nm diameter). Positive MRI contrast permits clearer distinction from image voids compared to negative contrast. T1-weighted MRI showed that such bacteria increased positive contrast 2.2-fold (p

Acetate-Resistant Yeast Strain For The Production Of A Fermentation Product

View page
US Patent:
20130071904, Mar 21, 2013
Filed:
May 27, 2011
Appl. No.:
13/578042
Inventors:
Yoram Barak - Menlo Park CA, US
International Classification:
C12P 7/10
US Classification:
435165
Abstract:
The present invention provides methods and compositions for fermentations comprising acetate-resistant yeast. The present invention provides methods for use of acetate-resistant yeast for the production of fermentation products.

Magnetotatic Bacteria Mri Positive Contract Enhancement Agent And Methods Of Use

View page
US Patent:
20130224122, Aug 29, 2013
Filed:
Mar 18, 2013
Appl. No.:
13/845923
Inventors:
The Board of Trustees of the Leland Stanford Junior University - , US
Michael Benoit - Menlo Park CA, US
A. C. Matin - Stanford CA, US
Yoram Barak - Menlo Park CA, US
Shay Keren - Haifa, IL
Dirk Mayer - Menlo Park CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61K 49/18
US Classification:
424 932
Abstract:
Magnetic resonance imaging (MRI) is enhanced by contrast agents such as superparamagnetic iron-oxide (SPIO) particles that resemble magnetite particles produced by magnetotactic bacteria. AMB-1 produces positive MRI contrast when generating ultrasmall magnetite particles (10-40 nm diameter). Positive MRI contrast permits clearer distinction from image voids compared to negative contrast. T1-weighted MRI showed that such bacteria increased positive contrast 2.2-fold (p

Production Of Fatty Alcohols From Engineered Microorganisms

View page
US Patent:
20160244787, Aug 25, 2016
Filed:
May 9, 2016
Appl. No.:
15/149859
Inventors:
- Redwood City CA, US
Fernando Valle - Burlingame CA, US
Yoram Barak - Greenwich CT, US
Louis Clark - San Francisco CA, US
Kristian Karlshoej - Naperville IL, US
Jonathan Vroom - South San Francisco CA, US
Jovana Nazor - Santa Clara CA, US
Claus M Krebber - Palo Alto CA, US
Kenneth Mitchell - Santa Clara CA, US
International Classification:
C12P 7/04
C12N 9/02
C12N 9/16
C12N 15/70
Abstract:
The invention generally relates to the production of a fatty alcohol composition from recombinant microbial cells. The fatty alcohols are produced by expressing a gene encoding a heterologous fatty alcohol forming acyl-CoA reductase (“FAR”); a gene encoding a heterologous thioesterase (“TE”) gene and a gene encoding an acyl-CoA synthetase (“ACS”).

Production Of Fatty Alcohols From Engineered Microorganisms

View page
US Patent:
20150176040, Jun 25, 2015
Filed:
Jul 19, 2013
Appl. No.:
14/415665
Inventors:
- Redwood city CA, US
Svetlana Balatskaya - Fremont CA, US
Yoram Barak - Greenwich CT, US
Louis Clark - San Francisco CA, US
Trish Choudhary - Foster City CA, US
Kristian Karlshoej - Naperville IL, US
Fernando Valle - Burlingame CA, US
Kaman Chan - San Bruno CA, US
Assignee:
Codexis, Inc. - Redwood City CA
International Classification:
C12P 7/64
C12N 9/04
C12N 9/16
A61K 8/34
C12N 9/88
C12N 9/00
C11D 3/20
C12N 9/10
C12N 9/02
Abstract:
Recombinant microorganisms are provided which have been engineered to produce fatty alcohols. Also provided are recombinant microorganisms which comprise a heterologous polynucleotide encoding a fatty alcohol reductase enzyme and an introduced polynucleotide encoding a β-ketoacyl acyl carrier protein synthase.

Production Of Fatty Alcohols From Engineered Microorganisms

View page
US Patent:
20150133698, May 14, 2015
Filed:
Apr 19, 2013
Appl. No.:
14/394817
Inventors:
- Redwood City CA, US
Fernando Valle - Burlingame CA, US
Yoram Barak - Greenwich CT, US
Louis Clark - San Francisco CA, US
Kristian Karlshoej - Naperville IL, US
International Classification:
C07C 31/125
A61Q 19/00
C11D 3/20
C12P 7/64
C12P 5/02
A61K 8/34
C12P 7/04
US Classification:
568840, 43525233, 435157, 435134, 435167
Abstract:
The invention generally relates to the production of a fatty alcohol composition from recombinant microbial cells. The fatty alcohols are produced by expressing a gene encoding a heterologous fatty alcohol forming acyl-CoA reductase (“FAR”); a gene encoding a heterologous thioesterase (“TE”) gene and a gene encoding an acyl-CoA synthetase (“ACS”).
Yoram Ben Barak from Belmont, CA, age ~75 Get Report